Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;37(2):637-643.
doi: 10.1007/s12325-019-01205-z. Epub 2019 Dec 24.

New Technologies and Applications in Sacral Neuromodulation: An Update

Stefan De Wachter  1   2 , Charles H Knowles  3 , Dean S Elterman  4 , Michael J Kennelly  5 , Paul A Lehur  6 , Klaus E Matzel  7 , Stefan Engelberg  8 , Philip E V Van Kerrebroeck  9
Affiliations
Review

New Technologies and Applications in Sacral Neuromodulation: An Update

Stefan De Wachter et al. Adv Ther. 2020 Feb.

Abstract

Recently rechargeable devices have been introduced for sacral neuromodulation (SNM) with conditional safety for full-body magnetic resonance imaging (MRI). Currently a recharge-free SNM device represents the standard implant; however, it is only approved for MRI head scans. As further new technologies with broader MRI capabilities are emerging, the advantages as well as disadvantages of both rechargeable versus recharge-free devices will be briefly discussed in this commentary from the perspective of patients, healthcare professionals, and providers.

Keywords: Fecal incontinence; Magnetic resonance imaging; Overactive bladder; Rechargeable battery; Sacral neuromodulation; Stimulator; Urology.

PubMed Disclaimer

References

    1. Coolen RL, Groen J, Blok B. Electrical stimulation in the treatment of bladder dysfunction: technology update. Med Devices (Auckl) 2019;12:337–345. - PMC - PubMed
    1. NeuroNews. Medtronic announces FDA submission for InterStim Micro neurostimulator and SureScan™ MRI leads. https://neuronewsinternational.com/interstim-fda-medtronic/. Accessed 14 Oct 2019.
    1. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol. 2005;28(4):326–328. doi: 10.1111/j.1540-8159.2005.50024.x. - DOI - PubMed
    1. Guzman-Negron JM, Pizarro-Berdichevsky J, Gill BC, Goldman HB. Can lumbosacral magnetic resonance imaging be performed safely in patients with a sacral neuromodulation device? An in vivo prospective study. J Urol. 2018;200(5):1088–1092. doi: 10.1016/j.juro.2018.05.095. - DOI - PubMed
    1. Goldman HB, Lloyd JC, Noblett KL, et al. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37(5):1823–1848. doi: 10.1002/nau.23515. - DOI - PubMed

Publication types

MeSH terms